Martina Recalde1,2, Veronica Davila-Batista1,3,4, Yesika Díaz1, Michael Leitzmann5, Isabelle Romieu6,7, Heinz Freisling3, Talita Duarte-Salles8. 1. Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Gran Via Corts Catalanes, 587 àtic, 08007, Barcelona, Spain. 2. Universitat Autònoma de Barcelona, Campus de Bellaterra, 08193, Bellaterra, Spain. 3. International Agency for Research on Cancer (IARC-WHO), 150 Cours Albert Thomas, 69008, Lyon, France. 4. Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 28029, Madrid, Spain. 5. Department of Epidemiology and Preventive Medicine, University of Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Germany. 6. Center for Research on Population Health, National Institute of Public Health, Mexico City, Mexico. 7. Hubert Department of Global Health, Emory University, Atlanta, GA, USA. 8. Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Gran Via Corts Catalanes, 587 àtic, 08007, Barcelona, Spain. tduarte@idiapjgol.org.
Abstract
BACKGROUND: A high body mass index (BMI) has been associated with increased risk of several cancers; however, whether BMI is related to a larger number of cancers than currently recognized is unclear. Moreover, whether waist circumference (WC) is more strongly associated with specific cancers than BMI is not well established. We aimed to investigate the associations between BMI and 26 cancers accounting for non-linearity and residual confounding by smoking status as well as to compare cancer risk estimates between BMI and WC. METHODS: Prospective cohort study with population-based electronic health records from Catalonia, Spain. We included 3,658,417 adults aged ≥ 18 years and free of cancer at baseline between 2006 and 2017. Our main outcome measures were cause-specific hazard ratios (HRs) with 99% confidence intervals (CIs) for incident cancer at 26 anatomical sites. RESULTS: After a median follow-up time of 8.3 years, 202,837 participants were diagnosed with cancer. A higher BMI was positively associated with risk of nine cancers (corpus uteri, kidney, gallbladder, thyroid, colorectal, breast post-menopausal, multiple myeloma, leukemia, non-Hodgkin lymphoma) and was positively associated with three additional cancers among never smokers (head and neck, brain and central nervous system, Hodgkin lymphoma). The respective HRs (per 5 kg/m2 increment) ranged from 1.04 (99%CI 1.01 to 1.08) for non-Hodgkin lymphoma to 1.49 (1.45 to 1.53) for corpus uteri cancer. While BMI was negatively associated to five cancer types in the linear analyses of the overall population, accounting for non-linearity revealed that BMI was associated to prostate cancer in a U-shaped manner and to head and neck, esophagus, larynx, and trachea, bronchus and lung cancers in an L-shaped fashion, suggesting that low BMIs are an approximation of heavy smoking. Of the 291,305 participants with a WC measurement, 27,837 were diagnosed with cancer. The 99%CIs of the BMI and WC point estimates (per 1 standard deviation increment) overlapped for all cancers. CONCLUSIONS: In this large Southern European study, a higher BMI was associated with increased risk of twelve cancers, including four hematological and head and neck (only among never smokers) cancers. Furthermore, BMI and WC showed comparable estimates of cancer risk associated with adiposity.
BACKGROUND: A high body mass index (BMI) has been associated with increased risk of several cancers; however, whether BMI is related to a larger number of cancers than currently recognized is unclear. Moreover, whether waist circumference (WC) is more strongly associated with specific cancers than BMI is not well established. We aimed to investigate the associations between BMI and 26 cancers accounting for non-linearity and residual confounding by smoking status as well as to compare cancer risk estimates between BMI and WC. METHODS: Prospective cohort study with population-based electronic health records from Catalonia, Spain. We included 3,658,417 adults aged ≥ 18 years and free of cancerat baseline between 2006 and 2017. Our main outcome measures were cause-specific hazard ratios (HRs) with 99% confidence intervals (CIs) for incident cancerat 26 anatomical sites. RESULTS: After a median follow-up time of 8.3 years, 202,837 participants were diagnosed with cancer. A higher BMI was positively associated with risk of nine cancers (corpus uteri, kidney, gallbladder, thyroid, colorectal, breast post-menopausal, multiple myeloma, leukemia, non-Hodgkin lymphoma) and was positively associated with three additional cancers among never smokers (head and neck, brain and central nervous system, Hodgkin lymphoma). The respective HRs (per 5 kg/m2 increment) ranged from 1.04 (99%CI 1.01 to 1.08) for non-Hodgkin lymphoma to 1.49 (1.45 to 1.53) for corpus uteri cancer. While BMI was negatively associated to five cancer types in the linear analyses of the overall population, accounting for non-linearity revealed that BMI was associated to prostate cancer in a U-shaped manner and to head and neck, esophagus, larynx, and trachea, bronchus and lung cancers in an L-shaped fashion, suggesting that low BMIs are an approximation of heavy smoking. Of the 291,305 participants with a WC measurement, 27,837 were diagnosed with cancer. The 99%CIs of the BMI and WC point estimates (per 1 standard deviation increment) overlapped for all cancers. CONCLUSIONS: In this large Southern European study, a higher BMI was associated with increased risk of twelve cancers, including four hematological and head and neck (only among never smokers) cancers. Furthermore, BMI and WC showed comparable estimates of cancer risk associated with adiposity.
Entities:
Keywords:
Adiposity; Body fat distribution; Body mass index; Body size; Cancer; Electronic health records; Obesity; Waist circumference
Authors: Bonaventura Bolíbar; Francesc Fina Avilés; Rosa Morros; Maria del Mar Garcia-Gil; Eduard Hermosilla; Rafael Ramos; Magdalena Rosell; Jordi Rodríguez; Manuel Medina; Sebastian Calero; Daniel Prieto-Alhambra Journal: Med Clin (Barc) Date: 2012-03-22 Impact factor: 1.725
Authors: Peter T Campbell; Christina C Newton; Cari M Kitahara; Alpa V Patel; Patricia Hartge; Jill Koshiol; Katherine A McGlynn; Hans-Olov Adami; Amy Berrington de González; Laura E Beane Freeman; Leslie Bernstein; Julie E Buring; Neal D Freedman; Yu-Tang Gao; Graham G Giles; Marc J Gunter; Mazda Jenab; Linda M Liao; Roger L Milne; Kim Robien; Dale P Sandler; Catherine Schairer; Howard D Sesso; Xiao-Ou Shu; Elisabete Weiderpass; Alicja Wolk; Yong-Bing Xiang; Anne Zeleniuch-Jacquotte; Wei Zheng; Susan M Gapstur Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-03-17 Impact factor: 4.254
Authors: Eleanor V Willett; Lindsay M Morton; Patricia Hartge; Nikolaus Becker; Leslie Bernstein; Paolo Boffetta; Paige Bracci; James Cerhan; Brian C-H Chiu; Pierluigi Cocco; Luigino Dal Maso; Scott Davis; Silvia De Sanjose; Karin Ekstrom Smedby; Maria Grazia Ennas; Lenka Foretova; Elizabeth A Holly; Carlo La Vecchia; Keitaro Matsuo; Marc Maynadie; Mads Melbye; Eva Negri; Alexandra Nieters; Richard Severson; Susan L Slager; John J Spinelli; Anthony Staines; Renato Talamini; Martine Vornanen; Dennis D Weisenburger; Eve Roman Journal: Int J Cancer Date: 2008-05-01 Impact factor: 7.396
Authors: Kimberly A Bertrand; Lauren R Teras; Emily L Deubler; Chun R Chao; Bernard A Rosner; Ke Wang; Charlie Zhong; Sophia S Wang; Brenda M Birmann Journal: Br J Cancer Date: 2022-07-15 Impact factor: 9.075